Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Role of GLP1a drugs after TAVI: insights from the MOTIVE registry

GLP-1 receptor agonists (GLP-1a) are a novel class of cardiometabolic drugs that have been shown to reduce the risk of major adverse cardiovascular events (MACE) and cardiovascular mortality in patients with type 2 diabetes, overweight, or obesity. Improved outcomes have also been reported in patients undergoing...

F. Giacobbe, A. Dalu, M. Balducci et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.